← Leaderboards
Stacy Loeb
New York University School Of Medicine
$2,727,347
Attributed
$2,727,347
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $724K · FY2013–25$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,727,347 · 2
By mechanism
R01$1,837,936 · 1
K07$889,411 · 1
Top collaborators
No co-investigators on record.
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Nan Jiang$897,829
- Brian Elbel$20,529,886
- Marie Bragg$5,242,817
- Dustin T Duncan$13,661,813
- Stephanie Lynn Albert$271,403
Others in their field
Top investigators on “Malignant Neoplasm Of Prostate”
- David Heimbrook · Leidos Biomedical Research, Inc.$255,843,614
- Leonard Freedman · Leidos Biomedical Research, Inc.$63,277,106
- Walter John Curran · Thomas Jefferson University$61,298,085
- Norman Wolmark · Nsabp Foundation, Inc.$54,888,134
- James J. Dignam · University Of Chicago$48,310,409
- Laurence H Baker · University Of Michigan At Ann Arbor$43,366,962
Research focus
Malignant Neoplasm Of ProstateMultidisciplinaryCancer CareDecision MakingQuality Of LifeLeadClinical CareUrologistRandomized TrialScreening For Prostate CancerSkillsPhysiciansMalignant NeoplasmsBlood TestsAnticancer ResearchCost EffectiveBiopsyCollaborationsDesignAdvanced DiseaseComparative EffectivenessBenefits And RisksCharacteristicsConsensus
Grant awards (9)
Addressing Circulation of Guideline-Discordant Information to Promote Optimal Prostate Cancer Care$582,362
R01 · FY2025 · CA · contact PI
Addressing Misinformation to Promote Equity in Prostate Cancer Care$531,583
R01 · FY2024 · CA · contact PI
Addressing Misinformation to Promote Equity in Prostate Cancer Care$627,381
R01 · FY2023 · CA · contact PI
Addressing Misinformation to Promote Equity in Prostate Cancer Care - Revision - 1$96,610
R01 · FY2023 · CA · contact PI
Optimal Strategy for Conservative Management of Prostate Cancer$177,326
K07 · FY2017 · CA · contact PI
Optimal Strategy for Conservative Management of Prostate Cancer$178,097
K07 · FY2016 · CA · contact PI
Optimal Strategy for Conservative Management of Prostate Cancer$178,762
K07 · FY2015 · CA · contact PI
Optimal Strategy for Conservative Management of Prostate Cancer$178,762
K07 · FY2014 · CA · contact PI
Optimal Strategy for Conservative Management of Prostate Cancer$176,464
K07 · FY2013 · CA · contact PI